This comprehensive review published in Circulation in 2007 gives a good insight into the problem of the cardiovascular risk and the use of COX 2 inhibitors or conventional NSAIDs. It covers the basic pharmacology as well as the clinical use of this important group of drugs. Importantly, it looks at the different CVS risk of the conventional NSAIDs.Diclofenac has a high risk (>2) while naproxen is low risk.
For more information, click on the link below:
Comments
Post a Comment